Oncolytic virus play OncoMyx raises $25M series A

Arizona State University spinout OncoMyx raised $25 million in a series A round to develop its oncolytic virus programs in

Read the full 208 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE